Devyser Diagnostics Investor Relations Material

Devyser Diagnostics AB provides diagnostic kits for DNA testing within hereditary diseases, oncology, and transplantation. The company offers products in the areas of transplantation, thalassemia, oncology, fetal RHD screening non-invasive prenatal testing, hereditary, cystic fibrosis, cardiovascular and male infertility testing, as well as rapid aneuploidy analysis. Its products are used to guide targeted cancer therapies; enable rapid prenatal diagnostics; and in post-transplant follow-up.